Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma

Clinical trial NCT00099047 · COMPLETED

Trial details

NCT number: NCT00099047
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Monoclonal Gammopathy of Undetermined Significance Multiple Myeloma Smoldering Multiple Myeloma

Start date: 2004-11-01
Primary completion: 2008-06-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.